Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06799481 · ClinicalTrials.gov registry record · NA

Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors

A NA study of Primary Brain Neoplasm and Cancer-related Cognitive Dysfunction, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
2
Study locations

NCT06799481: Recruiting NA study of Primary Brain Neoplasm and Cancer-related Cognitive Dysfunction, sponsored by Emory University.

NCT06799481 is a NA study of Primary Brain Neoplasm and Cancer-related Cognitive Dysfunction that is actively recruiting participants, run by Emory University. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06799481, a NA study of Primary Brain Neoplasm and Cancer-related Cognitive Dysfunction, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

This clinical trial evaluates the impact of a research intervention of virtually supervised exercise program (RISE) on cancer-related cognitive impairment (CRCI), physical activity in adolescent and young adult (AYA) brain tumor survivors. This clinical trial also evaluates the impact of RISE on the collection of microorganisms that exist in the intestines (gut microbiome). Up to 45% of AYA brain tumor survivors experience CRCI, including issues with attention and memory. CRCI can have a negative impact on education, independent living and can worsen long-term quality of life. Moderate-intensity levels of exercise, particularly aerobic and resistance training, have been shown to improve cognitive function. Additionally, exercise can change the composition and function of the gut microbiome, which may lead to improved cognitive function. Unfortunately, only about 50% of AYAs with cancer receive exercise information or meet the physical activity recommendations. Tailoring a virtually delivered exercise intervention to meet the unique needs of AYAs may improve access to exercise. Participating in the virtual home-based exercise intervention, RISE, may improve physical activity and cognitive impairment in AYA brain tumor survivors and may also help researchers understand the relationship of exercise on the gut microbiome and cognitive function.

Primary Outcome

Feasibility will be ≥ 50% enrollment of eligible survivors. Descriptive statistics (e.g., frequency and percentage) will be used.

Interventions

  • OTHER Medical Device Usage and Evaluation
  • BEHAVIORAL Behavioral Intervention
  • PROCEDURE Follow-Up
  • OTHER Internet-Based Intervention
  • OTHER Aerobic Exercise

Study Locations (2)

Georgia

  • Emory University Hospital - Atlanta

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-02-13
Est. Completion 2027-07-31
Phase NA
Emory University

1,208 total trials

What NCT06799481 shows while recruiting

NCT06799481 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 2 conditions, with Primary Brain Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Medical Device Usage and Evaluation is the first listed.

NCT06799481 reports a single indexed study location in Georgia, Texas.

Frequently Asked Questions

What is clinical trial NCT06799481 about?

NCT06799481 is a clinical study titled "Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors". This clinical trial evaluates the impact of a research intervention of virtually supervised exercise program (RISE) on cancer-related cognitive impairment (CRCI), physical activity in adolescent and young adult (AYA) brain tumor survivors. This clinical trial also evaluates the impact of RISE on the...

What is the current status of trial NCT06799481?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-02-13. Estimated completion is 2027-07-31.

What conditions does trial NCT06799481 study?

This clinical trial studies the following conditions: Primary Brain Neoplasm, Cancer-related Cognitive Dysfunction.

What interventions are being tested in trial NCT06799481?

The interventions under investigation include: Medical Device Usage and Evaluation (OTHER), Behavioral Intervention (BEHAVIORAL), Follow-Up (PROCEDURE), Internet-Based Intervention (OTHER), Aerobic Exercise (OTHER).

Who is sponsoring clinical trial NCT06799481?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06799481 being conducted?

This trial has 2 study locations across Georgia, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Primary Brain Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06799481's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06799481, the US trial registry maintained by the National Library of Medicine. NCT06799481 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.